BridgeMD
New treatment option for Meniscus Disorder
Official title Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment
ClinicalTrials.gov ID: NCT05882591
What this study is testing
- What it's testing
- The aim of this study is to assess outcomes of Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat
- Reduced concavity of the femoral metaphysis proximal to the medial femoral condyle confirmed on MRI
- Impingement of posterior horn of medial meniscus with the metaphysis of femur during full knee flexion confirmed arthroscopically
You likely can't join if
- Active knee inflammation
- Chondral injuries ICRS 3-4
- Extraarticular reasons of pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat
- Cyst or avascular changes within the femoral metaphysis adjacent to the planned localization of the procedure
The study team makes the final eligibility decision.
Where it's taking place
- Bełchatów, Łódź Voivodeship, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bełchatów, Łódź Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.